Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback